With glaring inequities in the supply and distribution of vaccines, the Biden administration has backed a plan to waive intellectual property rights for Covid-19 vaccines and treatments. We speak to Dr. Lindsay Newman, Director of Economics & Country Risk from IHS Markit on whether this could provide a solution to help end the pandemic.
Image Credit: Shutterstock.com

Can the World Contain the Latest Ebola Outbreak?
11:14

Is Malaysia Finally Moving on UEC Recognition?
10:02

LEAP Market 2.0: Better Access, Better Liquidity?
11:02